Molecular Templates, Inc.
(NASDAQ : THLD)

( )
THLD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -11.87%310.610.0%$5071.29m
BNTXBioNTech SE -4.91%334.480.0%$1509.60m
NVAXNovavax, Inc. -7.66%192.6578.2%$1000.81m
AMGNAmgen, Inc. 0.97%200.801.4%$596.73m
GILDGilead Sciences, Inc. 0.00%68.931.0%$502.66m
REGNRegeneron Pharmaceuticals, Inc. -0.93%630.592.7%$480.14m
VRTXVertex Pharmaceuticals, Inc. 9.66%205.001.9%$469.49m
LGVNLongeveron Inc. -22.20%20.430.0%$404.67m
ILMNIllumina, Inc. -2.10%357.663.3%$316.55m
SNSSSunesis Pharmaceuticals, Inc. -10.85%4.110.7%$287.30m
BIIBBiogen, Inc. -2.65%229.501.8%$286.58m
OCGNOcugen, Inc. -4.89%6.030.0%$251.60m
INCYIncyte Corp. -4.08%64.962.4%$161.20m
EXASEXACT Sciences Corp. -5.96%80.2818.0%$157.41m
SGENSeagen Inc. -1.09%158.255.8%$147.19m

Company Profile

Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2000 and is headquartered in Austin, TX.